PCRESOL Stock Latest News
Private CompaniesEarly RTX001 Data Point to Potential in Decompensated Cirrhosis2d agoRESOL
Private CompaniesResolution Therapeutics Highlights Interim RTX001 Data Ahead of Jefferies Conference4d agoRESOL
Private CompaniesResolution Therapeutics to Present Lung Fibrosis Therapy Data at ASGCT5d agoRESOL
Private CompaniesResolution Therapeutics Highlights RTX001 Liver Disease Data1w agoRESOL
Private CompaniesRTX001 Shows Interim Efficacy Signals in End-Stage Liver Disease Trial1w agoRESOL
Private CompaniesResolution Therapeutics to Present RTX001 Liver Disease Data at AASLD1w agoRESOLPrivate CompaniesResolution Therapeutics Prepares Clinical Data Presentations at Major Liver Conference2w agoRESOL
Private CompaniesResolution Therapeutics Highlights EMERALD Study Ahead of AASLD Data Presentation1M agoRESOL
Private CompaniesRegenerative Macrophage Data on RTX001 to Feature in Late-Breaking AASLD Presentation1M agoRESOL
Private CompaniesResolution Therapeutics Gains Industry Recognition for Clinical-Stage R&D Progress1M agoRESOL
Private CompaniesResolution Therapeutics Targets Partnership Opportunities at LSX World Congress USA1M agoRESOL
Private CompaniesResolution Therapeutics Reaches Key Milestone in RTX001 EMERALD Trial2M agoRESOL
Private CompaniesExperimental Cell Therapy for Advanced Liver Disease Draws Clinical Interest2M agoRESOL
Private CompaniesExperimental Regenerative Liver Therapy RTX001 Progresses Through Phase 1/2 Trial3M agoRESOL






